about
Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal CancerPathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breastMicroarray methods to identify factors determining breast cancer progression: potentials, limitations, and challenges.Digital image analysis of HER2 immunohistochemistry in gastric- and oesophageal adenocarcinoma: a validation study on biopsies and surgical specimens.Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment.Reproducibility and prognostic value of pattern of invasion scoring in low-stage oral squamous cell carcinoma.Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer.Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study.Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.The Failing Heart Stimulates Tumor Growth by Circulating Factors.Standardisation of the detection of germinal centres in salivary gland biopsies of patients with primary Sjögren's syndrome is needed to assess their clinical relevance.Validation of the ACR-EULAR criteria for primary Sjögren's syndrome in a Dutch prospective diagnostic cohort.Abatacept treatment of patients with primary Sjögren's syndrome results in a decrease of germinal centres in salivary gland tissue.Germinal centres in diagnostic labial gland biopsies of patients with primary Sjögren's syndrome are not predictive for parotid MALT lymphoma development.B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome.Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.Validation of the 4B5 rabbit monoclonal antibody in determining Her2/neu status in breast cancer.Need for consensus guidelines to standardise the assessment of germinal centres and other histopathological parameters in salivary gland tissue of patients with primary Sjögren's syndrome.Head and neck squamous cell carcinomas do not express EGFRvIII.Tumor-associated macrophages in breast cancer: Innocent bystander or important player?Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracersGlypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer DatabaseEffect of adjuvant radiotherapy on the local recurrence of oral squamous cell carcinoma with perineural invasion: a systematic reviewData-Driven prioritisation of antibody-drug conjugate targets in head and neck squamous cell carcinomaBreast Cancer Incidence After Risk-Reducing Salpingo-Oophorectomy in BRCA1 and BRCA2 Mutation CarriersThe expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome in ?pure? ductal carcinoma in situ of the breastp53 Overexpression is a Predictor of Local Recurrence After Treatment for Both in situ and Invasive Ductal Carcinoma of the BreastPresence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sjögren's syndrome patients.The expression pattern of MUC1 (EMA) is related to tumour characteristics and clinical outcome of invasive ductal breast carcinomaIn primary Sjögren's syndrome high absolute numbers and proportions of B cells in parotid glands predict responsiveness to rituximab as defined by ESSDAI, but not by SSRIViable tumor in salvage neck dissections in head and neck cancer: Relation with initial treatment, change of lymph node size and human papillomavirusCan ultrasound of the major salivary glands assess histopathological changes induced by treatment with rituximab in primary Sjögren's syndrome?Is the T Follicular Regulatory:Follicular Helper T Cell Ratio in Blood a Biomarker for Ectopic Lymphoid Structure Formation in Sjögren's Syndrome? Comment on the Article by Fonseca et alValidation of a whole-slide image-based teleconsultation networkHER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in-situ hybridisationDistinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic CarcinomasMicro-computed tomography (micro-CT) for intraoperative surgical margin assessment of breast cancer: A feasibility study in breast conserving surgeryProgenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sjögren's syndrome
P50
Q35029303-105DE904-1568-47BF-B0F7-F4A5F1E6F274Q35738875-19ED5021-1E5F-4C85-87EF-EA0E7E55EEC2Q35880956-11A26CB1-9119-43F9-8554-A426A4FC7CF5Q37291660-D58EC043-DBDE-4D5A-8C66-F826F6902E59Q40107322-124918E5-0E94-4C48-9C42-5D6135082BF0Q40117123-B0BDBF6D-8CB5-4E08-8FE4-3953B6315D93Q41680785-E831F126-1D89-4BA9-964C-1A5F3FBDD613Q46146478-2A5853E6-8260-433B-8280-897526C204EDQ46422598-A8B22FB0-0DA0-4E89-9054-7FE053B004FBQ47799622-061901CF-906C-498A-BEAB-9D3B6CFC91F5Q48212372-17EEA5CE-EF6B-4864-95A3-A8E98397B923Q49833083-D5366842-DD13-4368-8976-76BB23F5955AQ49911744-37D5F00E-3CC4-465B-B838-76C0EC48AFEDQ49997716-A807235E-42A6-4C74-95CD-328A882168EDQ50608750-E2026B0F-CA67-4EA6-82E4-936710371D18Q50889934-2C03FE27-A52F-43C4-A738-123900A0D383Q50978347-7F455A7F-F9D6-4506-AD69-66C8B81D858FQ51531354-3BF55FA8-4E40-4498-B98E-F5433A5B1E2DQ51755659-B91E6400-3647-4181-B0A9-ABCAA1FE7F81Q53918751-59DEDA3C-710C-40FE-80E6-997566D8D455Q54188931-271231F0-A884-4BA2-A414-4C92125D0AA3Q57107453-E004409A-986B-4818-B117-D1881C4951AAQ57155788-F2A0DC44-AB86-4446-B3F6-D87E2A2C3258Q57162273-4306B4FB-A653-4DE1-8A94-A0AEC04FB417Q57180630-7BA08552-BC2D-45A6-A37A-9EC7CA6B22D8Q57315791-F96B5F10-83A9-483B-A600-4F446A2169CBQ57892661-E96A4BE3-7395-4A69-8135-DD010CE07B57Q57892833-2688CEB2-3DC3-40E4-87E7-3DA61B1C4513Q57892837-2DA729F2-EE70-4BAC-910E-E7DFF600F952Q64925143-9CB5F193-20F2-4FC7-AE01-560CC250550DQ80654652-CD884BE2-C931-4540-BF4F-2E7D3985834DQ87430126-3FF6DC90-DA0D-4D8B-B11F-65B31BD940D9Q87593481-10952100-E9AE-4E18-9CC1-722F4367A4F2Q88012740-917945D8-BD43-45C2-A7C5-68710A411BADQ88041344-4CF7733E-ABD9-4521-B0C0-9F7B596AF026Q89076331-9A70BBF4-9477-4874-B934-4CDDFD066D26Q89493639-09D7DF0D-15D7-4D47-8AAB-0B4E79979DE9Q89742230-CD2BB52B-0542-4B2C-BBAD-67E329768507Q90060523-13884EE0-EDD6-423D-B480-0F825EF8C526Q90231876-FF178DC8-0AA2-4375-912A-55BCABB30084
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bert van der Vegt
@ast
Bert van der Vegt
@en
Bert van der Vegt
@es
Bert van der Vegt
@nl
Bert van der Vegt
@sl
type
label
Bert van der Vegt
@ast
Bert van der Vegt
@en
Bert van der Vegt
@es
Bert van der Vegt
@nl
Bert van der Vegt
@sl
prefLabel
Bert van der Vegt
@ast
Bert van der Vegt
@en
Bert van der Vegt
@es
Bert van der Vegt
@nl
Bert van der Vegt
@sl
P106
P21
P31
P496
0000-0002-2613-1506